Poster Abstract News Today

Media contacts: Investor contact: ...

NMDP to present new data on hematopoietic cell transplantation treatment effects in patients with hematological malignancies at ASCO. ...

MINNEAPOLIS, April 24, 2024 (GLOBE NEWSWIRE) -- NMDP℠, a global nonprofit leader in cell therapy, and CIBMTR® (Center for International Blood and Marrow Transplant Research®) will present new data on

Using marijuana regularly may raise the risk for heart failure, stroke or heart attack even after accounting for other cardiovascular risk factors such as Type 2 diabetes, high blood pressure and obesity, according to two preliminary studies to be presented at the American Heart Association's Scientific Sessions 2023.

<p>As more people across the U.S. use marijuana for medical and recreational reasons, two new studies suggest its regular intake may damage heart and brain health. In one study, daily use of marijuana raised the risk of developing heart failure by about one-third, even after considering other factors, compared to people who reported never using marijuana. In a second study, older people with any combination of Type 2 diabetes, high blood pressure and high cholesterol who used mari...

Baseline Characteristics from SEQUOIA-HCM to be Presented at HCMS Scientific Sessions on October 6, 2023...

/PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to...

The American Transplant Congress (ATC) 2022 resumes in person in Boston to showcase latest advances in transplantation with more than 3,000 attendees.

/PRNewswire/ -- Eisai announced today the presentation of six abstracts across various gastrointestinal cancers during the 2022 American Society of Clinical...

Apellis to Showcase Leadership in Retina at Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Nachrichtenquelle: globenewswire  |  16.04.2021, 18:44  |  82  10 accepted abstracts include five oral presentations from pioneering artificial intelligence (AI) collaboration Presentations support the potential of intravitreal pegcetacoplan, an investigational targeted C3 therapy, as the first treatment for ge...